Narix Pharmaceuticals Private Limited

Soriatane (Acitretin) Capsule Systemic Retinoid for Severe Psoriasis & Keratinization Disorders Narix Pharmaceuticals Narix Pharmaceuticals manufactures Acitretin Capsules, the only systemic retinoid approved for severe psoriasis � normalizing keratinocyte differentiation and reducing hyperproliferation in erythrodermic, pustular, and plaque psoriasis. Key Therapeutic Uses: � Severe plaque psoriasis � systemic retinoid therapy � Erythrodermic and pustular psoriasis � first-line � Congenital keratinization disorders (ichthyosis) � Darier's disease and pityriasis rubra pilaris Available Strengths: 10 mg 25 mg Product Highlights: � Only systemic retinoid for psoriasis � WHO-GMP, DCGI approved � Teratogenicity documentation provided � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AcitretinCapsule #SoriataneGeneric #SystemicRetinoid #PsoriasisTablet #SeverePsoriasis #AcitretinManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine